01 59Boehringer Ingelheim (Canada) Ltd.
01 62435730
02 62496249
03 22557801
04 22606650
05 12649922
06 62651019
07 32696558
08 32720450
09 12732803
10 62738367
11 22751833
12 22751834
13 22752434
14 22752435
15 42752437
16 32776296
17 42782179
18 42875706
01 22EMPAGLIFLOZIN | LINAGLIPTIN
02 10Linagliptin
03 27Linagliptin | Metformin Hydrochloride
01 22TABLET
02 37Tablet
01 62022-02-21
02 62023-08-18
03 22025-03-11
04 22026-05-02
05 12027-04-30
06 102027-05-03
07 32028-08-15
08 32029-04-02
09 12029-08-05
10 62029-10-15
11 82030-02-11
12 42030-02-12
13 32030-10-01
14 42030-11-26
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Brand Name : TRAJENTA
Patent Number : 2435730
Filing Date : 2002-02-21
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Patent Expiration Date : 2027-04-30
Date Granted : 2014-02-04
Brand Name : TRAJENTA
Patent Number : 2649922
Filing Date : 2007-04-30
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-04-30
Date Granted : 2014-02-04
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Brand Name : TRAJENTA
Patent Number : 2496249
Filing Date : 2003-08-18
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2496249
Filing Date : 2003-08-18
Strength per Unit : 2.5 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2435730
Filing Date : 2002-02-21
Strength per Unit : 2.5 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Patent Expiration Date : 2027-05-03
Date Granted : 2015-09-22
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2651019
Filing Date : 2007-05-03
Strength per Unit : 2.5 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-05-03
Date Granted : 2015-09-22
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2435730
Filing Date : 2002-02-21
Strength per Unit : 2.5 mg / 850 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-02-21
Date Granted : 2011-03-29
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2496249
Filing Date : 2003-08-18
Strength per Unit : 2.5 mg / 850 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Patent Expiration Date : 2027-05-03
Date Granted : 2015-09-22
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2651019
Filing Date : 2007-05-03
Strength per Unit : 2.5 mg / 850 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-05-03
Date Granted : 2015-09-22
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
Linagliptin, Metformin Hydrochloride
Brand Name : JENTADUETO
Patent Number : 2496249
Filing Date : 2003-08-18
Strength per Unit : 2.5 mg / 1000 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-08-18
Date Granted : 2012-01-24
